Summary
The * To whom correspondence should be addressed . It has been reported that the urinary excretion of N1-methylnicotinamide (MNA), one of the final metabolites of niacin, increased in patients with cirrhosis of the liver (5). But few investigations have been performed on the effect of cirrhosis of the liver or hepatitis on the activity of ACMSD and other metabolites of niacin, such as N1-methyl-4-pyridone-3-carboxamide (4-Py), or the tryptophan niacin conversion ratio. The most abundant metabolite in rats is not MNA but 4 Py. The excretion of 4-Py amounts to about 80% of the total amount of urinary nicotinamide and its metabolites (b). Therefore, 4-Py must be measured in rats. It is important to know the tryptophan-niacin conversion ratio in liver injury such as liver cirrhosis and hepatitis. Hepatitis has been shown to deve pp in response to many different causes such as virus, alcohol and various kinds of chemicals. D-Galactosamine (D-galN)-induced hepatitis has been well studied as a model of hepatitis which resembles viral hepatitis in histological features (7) . The injury of hepatocytes by D-galN was suggested to be developed through the suppression of mRNA (8, 9) or glycoprotein synthesis (10, 11) in association with the reduction of uridine triphosphate in the cells. In this experiment, we investigated the effect of D-galN-induced liver injury on hepatic ACMSD activity and the urinary excretion of niacin metabolites in rats. (Tokyo, Japan). N1-methyl-2-pyridone-5-carboxamide (2-Py) and 4-Py were syn thesized by the methods of Pullman and Colowick (12) The activities of aspartate aminotransferase (GOT) (EC 2.6.1.1) and alanine aminotransferase (GPT) (EC 2.6.1.2) in the serum were determined by a clinical enzyme assay kit, Iatrozyme TA-Lq.
Measurement of urinary excretion of nicotinamide and its metabolites. The urinary excretion of nicotinamide, MNA, 2-Py and 4-Py was simultaneously measured by the method of Shibata et al. (13, 16) .
Statistical analysis. The significance of differences was determined by un paired Student's t-test.
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RESULTS
Changes of body weight gain and transaminase activity Table 1 shows the body weight gain and the weights of organs of the experimental animals. The body weight gain, food intake and liver weight were lower in the D-galN group than in the control group. But the relative liver weight of the D-galN group was not significantly different from the control group. The activities of serum GOT and GPT were higher in the D-galN group than in the control group.
Urinary excretion of nicotinamide and its metabolites
As shown in Table 2 , the urinary excretion of MNA, 2-Py, 4-Py and nicotin amide+MNA+2-Py+4-Py were higher in the D-galN group than in the control group.
Enzyme activities
As shown in Table 3 Y EGASHIRA et al
DISCUSSION
Hepatic ACMSD activity in rats is known to be increased by dietary protein (4). On the other hand, dietary fat suppresses liver ACMSD activity (19). The hepatic ACMSD activities of the rats fed on diets containing 20% casein and 5% corn oil were reported to be low (4). In this experiment, rats were fed on a diet containing 40% casein to increase ACMSD activity. The urinary excretion of MNA in D-galN-treated rats was increased. There was a weak correlation between the serum GOT and urinary excretion of MNA (r=0.70, p<0.05). An injection of D-galN caused an increase in the urinary excretion of nicotinamide and its metab olites in rats with high-protein diets, and a decrease in liver ACMSD activity and tryptophan oxygenase activity. The increase in urinary excretion of nicotinamide and its metabolites in the D-galN group may be attributable to the decreased liver ACMSD activity. Naito et al reported that kynureninase, kynurenine 3-hydrox 
